Vitamin D antagonises the suppressive effect of inflammatory cytokines on CTLA-4 expression and regulatory function

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Jeffery, Louisa E ^a   Qureshi, Omar S ^a   Gardner, David ^a   Hou, Tie Z ^b   Briggs, Zoe ^a   Soskic, Blagoje ^b   Baker, Jennifer ^a   Raza, Karim ^a,c   Sansom, David M ^b  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c SANDWELL AND WEST BIRMINGHAM HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; B7 ANTIGEN; CALCITRIOL RECEPTOR; CD86 ANTIGEN; CD86 PROTEIN, HUMAN; CYTOKINE; VITAMIN D;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; ENDOCYTOSIS; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; TH17 CELL; ANIMAL; CHO CELL LINE; CRICETULUS; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; HAMSTER; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MONONUCLEAR CELL; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE;

MUS;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD80; ANTIGENS, CD86; CALCITRIOL; CHO CELLS; CRICETINAE; CRICETULUS; CTLA-4 ANTIGEN; CYTOKINES; ENDOCYTOSIS; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CALCITRIOL; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; VITAMIN D;

EID: 84940056402     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0131539     Document Type: Article

References (62)

1. Alegre ML, Noel PJ, Eisfelder BJ, Chuang E, Clark MR, Reiner SL, et al. Regulation of surface and intracellular expression of CTLA4 on mouse T cells. J Immunol. 1996; 157(11):4762-70. PMID: 8943377.
2. Lindsten T, Lee KP, Harris ES, Petryniak B, Craighead N, Reynolds PJ, et al. Characterization of CTLA-4 structure and expression on human T cells. J Immunol. 1993; 151(7):3489-99. PMID: 8397258.
3. Sansom DM, Walker LS. The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology. Immunological reviews. 2006; 212:131-48. PMID: 16903911.
4. Zheng Y, Manzotti CN, Burke F, Dussably L, Qureshi O, Walker LS, et al. Acquisition of suppressive function by activated human CD4+. J Immunol. 2008; 181(3):1683-91. PMID: 380.
5. Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity. 1995; 3:541-7. PMID: 309.
6. Waterhouse P, Penninger JM, Timms E, Wakeham A, Shahinian A, Lee KP, et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science (New York, NY. 1995; 270(5238):985-8. PMID: 205.
7. Kuehn HS, Ouyang W, Lo B, Deenick EK, Niemela JE, Avery DT, et al. Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4. Science (New York, NY. 2014; 345 (6204):1623-7. Epub 2014/09/13. doi: 10.1126/science.1255904 PMID: 25213377.
8. Schubert D, Bode C, Kenefeck R, Hou TZ, Wing JB, Kennedy A, et al. Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations. Nature medicine. 2014; 20(12):1410-6. Epub 2014/10/21. doi: 10.1038/nm.3746 PMID: 25329329.
9. Walker LS, Sansom DM. The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses. Nature reviews. 2011; 11(12):852-63. Epub 2011/11/26. doi: 10.1038/nri3108 PMID: 22116087.
10. Bour-Jordan H, Esensten JH, Martinez-Llordella M, Penaranda C, Stumpf M, Bluestone JA. Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/ B7 family. Immunological reviews. 2011; 241(1):180-205. Epub 2011/04/15. doi: 10.1111/j.1600-065X.2011.01011.x PMID: 21488898; PubMed Central PMCID: PMC3077803.
11. Rudd CE. The reverse stop-signal model for CTLA4 function. Nature reviews. 2008; 8(2):153-60. Epub 2008/01/26. doi: 10.1038/nri2253 PMID: 18219311.
12. Egen JG, Allison JP. Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength. Immunity. 2002; 16(1):23-35. PMID: 11825563.
13. Linsley PS, Bradshaw J, Greene J, Peach R, Bennett KL, Mittler RS. Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement. Immunity. 1996; 4(6):535-43. PMID: 8673700.
14. Qureshi OS, Kaur S, Hou TZ, Jeffery LE, Poulter NS, Briggs Z, et al. Constitutive Clathrin-mediated Endocytosis of CTLA-4 Persists during T Cell Activation. J Biol Chem. 2012; 287(12):9429-40. Epub 2012/01/21. M111.304329 [pii] doi: 10.1074/jbc.M111.304329 PMID: 22262842.
15. Qureshi OS, Zheng Y, Nakamura K, Attridge K, Manzotti C, Schmidt EM, et al. Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science (New York, NY. 2011; 332(6029):600-3. Epub 2011/04/09. doi: 10.1126/science.1202947 PMID: 21474713; PubMed Central PMCID: PMC3198051.
16. Peters A, Lee Y, Kuchroo VK. The many faces of Th17 cells. Current opinion in immunology. 2011; 23 (6):702-6. Epub 2011/09/09. doi: 10.1016/j.coi.2011.08.007 PMID: 21899997; PubMed Central PMCID: PMC3232281.
17. Stockinger B, Veldhoen M. Differentiation and function of Th17 T cells. Current opinion in immunology. 2007; 19(3):281-6. Epub 2007/04/17. doi: 10.1016/j.coi.2007.04.005 PMID: 17433650.
18. Abe M, Hiasa Y, Onji M. T helper 17 cells in autoimmune liver diseases. Clinical & developmental immunology. 2013; 2013:607073. Epub 2013/11/14. doi: 10.1155/2013/607073 PMID: 24223606; PubMed Central PMCID: PMC3810350.
19. Maddur MS, Miossec P, Kaveri SV, Bayry J. Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. The American journal of pathology. 2012; 181(1):8-18. Epub 2012/05/30. doi: 10.1016/j.ajpath.2012.03.044 PMID: 22640807.
20. Marwaha A, Leung N, McMurchy AN, Levings M. TH17 cells in autoimmunity and immunodeficiency: protective or pathogenic? Frontiers in Immunology. 2012;3. doi: 10.3389/fimmu.2012.00129 PMID: 22566889
21. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006; 441(7090):235-8. PMID: 105.
22. Yang XO, Nurieva R, Martinez GJ, Kang HS, Chung Y, Pappu BP, et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity. 2008; 29(1):44-56. PMID: 366. doi: 10.1016/j.immuni.2008.05.007
23. Manel N, Unutmaz D, Littman DR. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat Immunol. 2008; 9(6):641-9. PMID: 2. doi: 10.1038/ni.1610
24. Volpe E, Servant N, Zollinger R, Bogiatzi SI, Hupe P, Barillot E, et al. A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T (H)-17 responses. Nat Immunol. 2008; 9(6):650-7. PMID: 100. doi: 10.1038/ni.1613
25. Agmon-Levin N, Theodor E, Segal RM, Shoenfeld Y. Vitamin D in systemic and organ-specific autoimmune diseases. Clinical reviews in allergy & immunology. 2013; 45(2):256-66. Epub 2012/12/15. doi: 10.1007/s12016-012-8342-y PMID: 23238772.
26. Antico A, Tampoia M, Tozzoli R, Bizzaro N. Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature. Autoimmunity reviews. 2012; 12(2):127-36. Epub 2012/07/11. doi: 10.1016/j.autrev.2012.07.007 PMID: 22776787.
27. Gatenby P, Lucas R, Swaminathan A. Vitamin D deficiency and risk for rheumatic diseases: an update. Current opinion in rheumatology. 2013; 25(2):184-91. Epub 2013/02/02. doi: 10.1097/BOR.0b013e32835cfc16 PMID: 23370372.
28. Kriegel MA, Manson JE, Costenbader KH. Does vitamin D affect risk of developing autoimmune disease?: a systematic review. Seminars in arthritis and rheumatism. 2011; 40(6):512-31e8. Epub 2010/ 11/05. doi: 10.1016/j.semarthrit.2010.07.009 PMID: 21047669; PubMed Central PMCID: PMC3098920.
29. Yang CY, Leung PS, Adamopoulos IE, Gershwin ME. The implication of vitamin D and autoimmunity: a comprehensive review. Clinical reviews in allergy & immunology. 2013; 45(2):217-26. Epub 2013/01/30. doi: 10.1007/s12016-013-8361-3 PMID: 23359064.
30. Cantorna MT. Vitamin D, multiple sclerosis and inflammatory bowel disease. Arch Biochem Biophys. 2012; 523(1):103-6. Epub 2011/11/17. doi: 10.1016/j.abb.2011.11.001 PMID: 22085500; PubMed Central PMCID: PMC3374859.
31. Chang JH, Cha HR, Lee DS, Seo KY, Kweon MN. 1,25-Dihydroxyvitamin D3 inhibits the differentiation and migration of T(H)17 cells to protect against experimental autoimmune encephalomyelitis. PLoS One. 2010; 5(9):e12925. Epub 2010/10/05. doi: 10.1371/journal.pone.0012925 PMID: 20886077; PubMed Central PMCID: PMC2944871.
32. Mathieu C, Waer M, Laureys J, Rutgeerts O, Bouillon R. Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3. Diabetologia. 1994; 37(6):552-8. PMID: 434.
33. Mayne CG, Spanier JA, Relland LM, Williams CB, Hayes CE. 1,25-Dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis. Eur J Immunol. 2011; 41(3):822-32. Epub 2011/02/03. doi: 10.1002/eji.201040632 PMID: 21287548.
34. Jeffery LE, Burke F, Mura M, Zheng Y, Qureshi OS, Hewison M, et al. 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol. 2009; 183(9):5458-67. Epub 2009/10/22. doi: 10.4049/jimmunol.0803217 PMID: 19843932; PubMed Central PMCID: PMC2810518.
35. Yokozeki H, Katayama I, Ohki O, Arimura M, Takayama K, Matsunaga T, et al. Interferon-gamma differentially regulates CD80 (B7-1) and CD86 (B7-2/B70) expression on human Langerhans cells. The British journal of dermatology. 1997; 136(6):831-7. Epub 1997/06/01. PMID: 9217813.
36. Shankar G, Pestano LA, Bosch ML. Interferon-gamma Added During Bacillus Calmette-Guerin Induced Dendritic Cell Maturation Stimulates Potent Th1 Immune Responses. Journal of translational medicine. 2003; 1(1):7. Epub 2003/10/29. doi: 10.1186/1479-5876-1-7 PMID: 14580262; PubMed Central PMCID: PMC239912.
37. Ozawa H, Aiba S, Nakagawa, Tagami H. Interferon-gamma and interleukin-10 inhibit antigen presentation by Langerhans cells for T helper type 1 cells by suppressing their CD80 (B7-1) expression. Eur J Immunol. 1996; 26(3):648-52. Epub 1996/03/01. doi: 10.1002/eji.1830260321 PMID: 8605933.
38. Collins AV, Brodie DW, Gilbert RJ, Iaboni A, Manso-Sancho R, Walse B, et al. The interaction properties of costimulatory molecules revisited. Immunity. 2002; 17(2):201-10. Epub 2002/08/28. PMID: 12196291.
39. Schwartz RH. T cell anergy. Annual review of immunology. 2003; 21:305-34. Epub 2002/12/10. doi: 10.1146/annurev.immunol.21.120601.141110 PMID: 12471050.
40. Read S, Malmstrom V, Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med. 2000; 192(2):295-302. PMID: 10899916.
41. Takahashi T, Tagami T, Yamazaki S, Uede T, Shimizu J, Sakaguchi N, et al. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med. 2000; 192(2):303-10. PMID: 375.
42. Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T, Miyara M, Fehervari Z, et al. CTLA-4 control over Foxp3+ regulatory T cell function. Science (New York, NY. 2008; 322(5899):271-5. PMID: 379.
43. Corse E, Allison JP. Cutting edge: CTLA-4 on effector T cells inhibits in trans. J Immunol. 2012; 189 (3):1123-7. Epub 2012/07/04. doi: 10.4049/jimmunol.1200695 PMID: 22753941.
44. Wang CJ, Kenefeck R, Wardzinski L, Attridge K, Manzotti C, Schmidt EM, et al. Cutting edge: cell-extrinsic immune regulation by CTLA-4 expressed on conventional T cells. J Immunol. 2012; 189 (3):1118-22. Epub 2012/07/04. doi: 10.4049/jimmunol.1200972 PMID: 22753931; PubMed Central PMCID: PMC3442233.
45. Peggs KS, Quezada SA, Chambers CA, Korman AJ, Allison JP. Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies. J Exp Med. 2009; 206(8):1717-25. Epub 2009/07/08. doi: 10.1084/jem.20082492 PMID: 19581407; PubMed Central PMCID: PMC2722174.
46. Jain N, Nguyen H, Chambers C, Kang J. Dual function of CTLA-4 in regulatory T cells and conventional T cells to prevent multiorgan autoimmunity. Proceedings of the National Academy of Sciences of the United States of America. 2010; 107(4):1524-8. Epub 2010/01/19. doi: 10.1073/pnas.0910341107 PMID: 20080649; PubMed Central PMCID: PMC2824392.
47. Flores-Borja F, Jury EC, Mauri C, Ehrenstein MR. Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis. Proceedings of the National Academy of Sciences of the United States of America. 2008; 105(49):19396-401. PMID: 19036923. doi:10.1073/pnas.0806855105
48. Liu X, Gao N, Li M, Xu D, Hou Y, Wang Q, et al. Elevated levels of CD4(+)CD25(+)FoxP3(+) T cells in systemic sclerosis patients contribute to the secretion of IL-17 and immunosuppression dysfunction. PLoS One. 2013; 8(6):e64531. Epub 2013/06/19. doi: 10.1371/journal.pone.0064531 PMID: 23776439; PubMed Central PMCID: PMC3679128.
49. Luczynski W, Wawrusiewicz-Kurylonek N, Stasiak-Barmuta A, Urban R, Ilendo E, Urban M, et al. Diminished expression of ICOS, GITR and CTLA-4 at the mRNA level in T regulatory cells of children with newly diagnosed type 1 diabetes. Acta biochimica Polonica. 2009; 56(2):361-70. PMID: 19547759.
50. Fritsche J, Mondal K, Ehrnsperger A, Andreesen R, Kreutz M. Regulation of 25-hydroxyvitamin D3-1 alpha-hydroxylase and production of 1 alpha,25-dihydroxyvitamin D3 by human dendritic cells Blood. 2003; 102(9):3314-6. PMID: 444.
51. Jeffery LE, Wood AM, Qureshi OS, Hou TZ, Gardner D, Briggs Z, et al. Availability of 25-Hydroxyvitamin D3 to APCs Controls the Balance between Regulatory and Inflammatory T Cell Responses. J Immunol. 2012; 189(11):5155-64. Epub 2012/10/23. doi: 10.4049/jimmunol.1200786 PMID: 23087405; PubMed Central PMCID: PMC3504609.
52. Krutzik SR, Hewison M, Liu PT, Robles JA, Stenger S, Adams JS, et al. IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway. J Immunol. 2008; 181 (10):7115-20. Epub 2008/11/05. doi: 181/10/7115 [pii]. PMID: 18981132; PubMed Central PMCID: PMC2678236.
53. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, et al. Toll-like receptor triggering of a vitamin D- mediated human antimicrobial response Science (New York, NY. 2006; 311(5768):1770-3. PMID: 358.
54. Adorini L, Penna G, Giarratana N, Uskokovic M. Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases. JCell Biochem. 2003; 88(2):227-33. PMID: 382.
55. Berer A, Stockl J, Majdic O, Wagner T, Kollars M, Lechner K, et al. 1,25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro. ExpHematol. 2000; 28(5):575-83. PMID: 363.
56. Penna G, Adorini L. 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol. 2000; 164 (5):2405-11. PMID: 347.
57. Butty V, Roy M, Sabeti P, Besse W, Benoist C, Mathis D. Signatures of strong population differentiation shape extended haplotypes across the human CD28, CTLA4, and ICOS costimulatory genes. Proceedings of the National Academy of Sciences of the United States of America. 2007; 104(2):570-5. Epub 2007/01/02. doi: 10.1073/pnas.0610124104 PMID: 17197413; PubMed Central PMCID: PMC1766426.
58. Ghaderi A. CTLA4 gene variants in autoimmunity and cancer: a comparative review. Iranian journal of immunology: IJI. 2011; 8(3):127-49. Epub 2011/09/21. doi: IJIv8i3A1 PMID: 21931200.
59. Gough SC, Walker LS, Sansom DM. CTLA4 gene polymorphism and autoimmunity. Immunological reviews. 2005; 204:102-15. Epub 2005/03/26. doi: 10.1111/j.0105-2896.2005.00249.x PMID: 15790353.
60. Lee YH, Harley JB, Nath SK. CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis. Human genetics. 2005; 116(5):361-7. Epub 2005/02/03. doi: 10.1007/s00439-004-1244-1 PMID: 15688186.
61. Li M, Zheng H, Li T, Gao P, Zhang XL, Liu DW. Cytotoxic T-lymphocyte associated antigen-4 gene polymorphisms and primary biliary cirrhosis: a systematic review. Journal of gastroenterology and hepatology. 2012; 27(7):1159-66. Epub 2012/03/15. doi: 10.1111/j.1440-1746.2012.07118.x PMID: 22414241.
62. Ramagopalan SV, Heger A, Berlanga AJ, Maugeri NJ, Lincoln MR, Burrell A, et al. A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res. 2010; 20(10):1352-60. Epub 2010/08/26. doi: 10.1101/gr.107920.110 PMID: 20736230; PubMed Central PMCID: PMC2945184.